Humate-P
Biological
CSL Behring
Total Payments
$98,660
Transactions
96
Doctors
27
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $1,348 | 1 | 0 |
| 2021 | $25.11 | 1 | 1 |
| 2020 | $187.53 | 9 | 8 |
| 2019 | $42.75 | 2 | 2 |
| 2018 | $97,056 | 83 | 16 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $82,515 | 16 | 83.6% |
| Travel and Lodging | $9,194 | 14 | 9.3% |
| Food and Beverage | $4,334 | 62 | 4.4% |
| Unspecified | $2,547 | 2 | 2.6% |
| Education | $70.00 | 2 | 0.1% |
Payments by Type
General
$96,113
94 transactions
Research
$2,547
2 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| The Role of the vWF Propeptide in Platelet Adhesion/aggregatation and Associated Fibrin Formation in Flowing Blood from Patients with type 1 von Willebrand Disease | CSL Behring | $1,348 | 0 |
| The Role of the vWF Propeptide in Platelet Adhesionaggregation and Associated Fibrin Formation in Flowing Blood from Patients with Type 1 von Willebrand Disease | CSL Behring | $1,199 | 0 |
Top Doctors Receiving Payments for Humate-P — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Maria Isabel Rosas Garcia | Pediatric Infectious Diseases | Naples, FL | $17.11 | 1 |
| , M.D., M.P.H | Pediatric Hematology-Oncology | Loxahatchee, FL | $16.85 | 1 |
| , MD | Neurology | Salem, VA | $15.13 | 1 |
Ad
Manufacturing Companies
- CSL Behring $98,660
Product Information
- Type Biological
- Total Payments $98,660
- Total Doctors 27
- Transactions 96
About Humate-P
Humate-P is a biological associated with $98,660 in payments to 27 healthcare providers, recorded across 96 transactions in the CMS Open Payments database. The primary manufacturer is CSL Behring.
Payment data is available from 2018 to 2022. In 2022, $1,348 was paid across 1 transactions to 0 doctors.
The most common payment nature for Humate-P is "Honoraria" ($82,515, 83.6% of total).
Humate-P is associated with 2 research studies, including "The Role of the vWF Propeptide in Platelet Adhesion/aggregatation and Associated Fibrin Formation in Flowing Blood from Patients with type 1 von Willebrand Disease" ($1,348).